News:

Just a reminder: if you haven't signed in for six months or more, please do so if you wish to remain active...no need to post, just sign in so we know you're still interested.

Main Menu

Profile of Rituximab Responders

Started by markt, January 24, 2019, 04:57:16 AM

Previous topic - Next topic

markt

I thought it would be interesting to capture a snapshot of folks on here who have responded favorably to Rituximab in the past (to get a non-scientific general idea for folks considering it). 

By that I mean, did it help or not and then simply note your bloodwork (or clinical picture / presentation of Sjogrens).

Me myself, I had a marked improvement in oral dryness, and thickness of saliva.  I also had improved skin texture and eyelid MGD lessened (my lashes looked normal).  I could not tell that there was a subjective improvement in ocular dryness.  I began a regimen that is 2 in infusions, 04 months apart.  I was diagnosed and treated with RTX only 5 months after symptom onset, as my initial intro to Sjogrens was swift and the immune response was captured in my serum samples.  I have had no flares since... dryness does increase a bit between infusions so far.  No arthralgia, fatigue, or brain fog issues.

I fall squarely into the patient profile described in paragraph 5 (Predictors of response to rituximab):   https://www.sciencedirect.com/science/article/pii/S1521661617301742

32 Yr Old Male, highly positive for SP-1 and CA-6 antibodies (hence the positive ANA), slightly elevated TPO antibodies, Slight RF / anti-CCP positivity, low blood compliment C4,  elevated serum IgG, low IFN activity, etc.  I also had a lower focus score (0.37) and a lower salivary gland ultrasonography grades (no ectopic lymphocyte lesions).